间硝基苯乙酸甲酯 | 10268-12-9

• 物质功能分类: 化学试剂 - 有机试剂 - 硝基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 间硝基苯乙酸甲酯
• 中文别名: 3-硝基苯乙酸甲酯
• 英文名称: methyl 3-nitrophenylacetate
• 英文别名: methyl 2-(3-nitrophenyl)acetate；methyl m-nitrophenylacetate
• CAS: 10268-12-9
• 化学式: C₉H₉NO₄
• mdl: MFCD08669939
• 分子量: 195.175
• InChiKey: BFGYITRIATVARH-UHFFFAOYSA-N

物化性质

• 熔点：
  28 °C
• 沸点：
  130°C/20mmHg(lit.)
• 密度：
  1.266±0.06 g/cm3(Predicted)
• 保留指数：
  1613

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  72.1
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2916399090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-nitrophenylacetate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-nitrophenylacetate
CAS number: 10268-12-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9NO4
Molecular weight: 195.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

间硝基苯乙酸甲酯可作为有机合成中间体和医药中间体使用，主要应用于实验室研发和化工生产过程中。

反应信息

• 作为反应物：
  描述：

  间硝基苯乙酸甲酯 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 6.0h， 生成 3-硝基苯乙醇
  参考文献：
  名称：

  具有单取代苯基乙醇部分的咖啡酸酯的抗增殖活性和SAR

  摘要：

  合成了一系列具有单取代苯基乙醇部分的CAPE衍生物，并通过MTT分析对4种人类癌细胞系（Hela，DU-145，MCF-7和ECA-109）的生长进行了评估。首次系统地研究了取代基对抗增殖活性的影响。发现苯乙醇部分的2'-位的给电子和疏水取代基可以显着增强CAPE的抗增殖活性。作为一种新型咖啡酸酯的2'-丙氧基衍生物表现出出色的效力（ 分别针对Hela和DU-145的IC 50 = 0.4±0.02和0.6±0.03μM）。

  DOI：

  10.1016/j.bmcl.2016.12.007
• 作为产物：
  描述：

  3-硝基苯乙酸 在 2-氯-1-甲基吡啶碘化物 作用下， 以 二氯甲烷 为溶剂， 反应 2.25h， 生成 间硝基苯乙酸甲酯
  参考文献：
  名称：

  转换途径：室温中性溶剂分解和酰胺取代

  摘要：

  粘连或扭曲：通过在氮原子上引入位阻，可以形成带有吸电子α取代基（Z = Ar，PhSO 2，P（O）（OR）2，CN或CO 2 R）的稳定的线性酰胺。通过消除-加成机理诱导其经历溶剂分解和取代反应（见图）。该过程的关键是绕酰胺键和α取代基Z旋转的低障碍。

  DOI：

  10.1002/anie.201107117

文献信息

• [EN] PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS<br/>[FR] PYRROLOTRIAZINES EN TANT QU'INHIBITEURS D'ALK ET DE JAK2
  申请人：CEPHALON INC

  公开号：WO2010071885A1

  公开（公告）日：2010-06-24

  The present invention provides a compound of formula (I) or a salt form thereof, wherein Q1, Q2, Q3, and Q4 are as defined herein. The compound of formula (I) has ALK and/or JAK2 inhibitory activity, and may be used to treat proliferative disorders.

  本发明提供了一种式（I）的化合物或其盐形式，其中Q1、Q2、Q3和Q4如本文所定义。式（I）的化合物具有ALK和/或JAK2抑制活性，并可用于治疗增殖性疾病。
• [EN] BORON-CONTAINING SMALL MOLECULES<br/>[FR] PETITES MOLECULES CONTENANT DU BORE
  申请人：ANACOR PHARMACEUTICALS INC

  公开号：WO2011060196A1

  公开（公告）日：2011-05-19

  This invention relates to 6-substituted benzoxaborole compounds of the following formula and their use for treating bacterial infections.

  这项发明涉及以下公式的6-取代苯硼酯化合物及其用于治疗细菌感染的用途。
• 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase
  作者：Christopher J. Matheson、Christopher R. Coxon、Richard Bayliss、Kathy Boxall、Benoit Carbain、Andrew M. Fry、Ian R. Hardcastle、Suzannah J. Harnor、Corine Mas-Droux、David R. Newell、Mark W. Richards、Mangaleswaran Sivaprakasam、David Turner、Roger J. Griffin、Bernard T. Golding、Céline Cano

  DOI：10.1039/d0md00074d

  日期：——

  Renewed interest in covalent inhibitors of enzymes implicated in disease states has afforded several agents targeted at protein kinases of relevance to cancers. We now report the design, synthesis and biological evaluation of 6-ethynylpurines that act as covalent inhibitors of Nek2 by capturing a cysteine residue (Cys22) close to the catalytic domain of this protein kinase. Examination of the crystal

  人们对与疾病状态有关的酶的共价抑制剂重新产生了兴趣，从而提供了几种针对与癌症相关的蛋白激酶的药物。我们现在报告了 6-乙炔基嘌呤的设计、合成和生物学评价，6-乙炔基嘌呤通过捕获靠近该蛋白激酶催化结构域的半胱氨酸残基 (Cys22) 来充当 Nek2 的共价抑制剂。对与 Nek2 复合的非共价抑制剂 3-((6-环己基甲氧基-7 H-嘌呤-2-基)氨基)苯甲酰胺的晶体结构的检查表明，用乙炔基取代烷氧基放置了炔烃的末端接近Cys22并且处于与迈克尔加成的立体电子学要求兼容的位置。制备了一系列 6-乙炔基嘌呤并建立了抑制 Nek2 的结构活性关系 (SAR)。 6-乙炔基-N-苯基-7 H-嘌呤-2-胺 [IC 50 0.15 μM (Nek2)] 和 4-((6-乙炔基-7 H-嘌呤-2-基)氨基)苯磺酰胺 (IC 50 0.14)选择 Nek2 的抑制模式来确定 Nek2 的抑制模式，该抑制模式具有时间依赖性，不能通过添加
• Heteroaromatic glucokinase activators
  申请人：——

  公开号：US20010039344A1

  公开（公告）日：2001-11-08

  2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

  2,3-二取代N-杂环丙酰胺，其中2-位取代为取代苯基，3-位取代为环烷基环，这些丙酰胺是葡萄糖激酶激活剂，可增加胰岛素分泌，用于治疗2型糖尿病。
• Blue Light-Emitting Diode-Mediated <i>In Situ</i> Generation of Pyridinium and Isoquinolinium Ylides from Aryl Diazoesters: Their Application in the Synthesis of Diverse Dihydroindolizine
  作者：Saibal Sar、Souvik Guha、Tejas Prabakar、Debajit Maiti、Subhabrata Sen

  DOI：10.1021/acs.joc.1c01209

  日期：2021.9.3

  1/2, aryl diazoesters 3, and acrylic ester/3-alkenyl oxindoles 5/6 provide various dihydroindolizines 7 to 9 in excellent yield. The principle of the strategy is photolytic generation of nitrogen ylides from N-heteroarenes and aryl diazoesters and their subsequent [3 + 2] cycloaddition reaction with dipolarophiles. Detailed mechanistic analysis of the transformation through control experiments establishes

  蓝色发光二极管介导的环境上可持续的三个组分吡啶中/反应异喹啉1/2，芳基diazoesters 3，和丙烯酸酯/ 3-链烯基羟吲哚5/6提供各种dihydroindolizines 7到9的优良率。该策略的原理是从 N-杂芳烃和芳基重氮酯光解生成氮叶立德，以及它们随后与偶极体的 [3 + 2] 环加成反应。通过对照实验对转化进行详细的机械分析，将这一策略作为光解多组分反应的基础。